PortfoliosLab logoPortfoliosLab logo
GENE.L vs. CHRG.L
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

GENE.L vs. CHRG.L - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in UBS ETF (IE) Global Gender Equality UCITS ETF (USD) A-acc (GENE.L) and WisdomTree Battery Solutions UCITS ETF - USD Acc (CHRG.L). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, GENE.L achieves a 3.70% return, which is significantly lower than CHRG.L's 33.50% return.


GENE.L

1D
0.53%
1M
0.84%
YTD
3.70%
6M
6.46%
1Y
16.95%
3Y*
12.36%
5Y*
8.55%
10Y*

CHRG.L

1D
-0.93%
1M
3.06%
YTD
33.50%
6M
30.24%
1Y
105.73%
3Y*
14.40%
5Y*
5.81%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

GENE.L vs. CHRG.L - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
GENE.L
UBS ETF (IE) Global Gender Equality UCITS ETF (USD) A-acc
3.70%14.86%10.70%11.06%-1.37%17.63%12.36%
CHRG.L
WisdomTree Battery Solutions UCITS ETF - USD Acc
33.50%44.29%-11.91%-9.67%-19.10%14.89%72.90%

Correlation

The correlation between GENE.L and CHRG.L is 0.29, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.29

Correlation (3Y)
Calculated over the trailing 3-year period

0.43

Correlation (5Y)
Calculated over the trailing 5-year period

0.51

Correlation (All Time)
Calculated using the full available price history since Mar 3, 2020

0.54

Over the past year, the correlation between GENE.L and CHRG.L has dropped to 0.29 - well below their long-term average of 0.54, suggesting their price drivers have been diverging.

GENE.L vs. CHRG.L - Sectors Allocation Comparison


Sectors
GENE.L
CHRG.L

Financial Services

26.3%

-

Healthcare

12.8%

-

Consumer Cyclical

11.2%
15.5%

Consumer Defensive

10.4%
0.0%

Utilities

8.3%
1.3%

Communication Services

7.8%

-

Real Estate

6.8%

-

Basic Materials

5.8%
20.3%

Technology

5.3%
8.2%

Industrials

5.3%
48.7%

Energy

-

6.1%

Financial Services

GENE.L
26.3%
CHRG.L

-

Healthcare

GENE.L
12.8%
CHRG.L

-

Consumer Cyclical

GENE.L
11.2%
CHRG.L
15.5%

Consumer Defensive

GENE.L
10.4%
CHRG.L
0.0%

Utilities

GENE.L
8.3%
CHRG.L
1.3%

Communication Services

GENE.L
7.8%
CHRG.L

-

Real Estate

GENE.L
6.8%
CHRG.L

-

Basic Materials

GENE.L
5.8%
CHRG.L
20.3%

Technology

GENE.L
5.3%
CHRG.L
8.2%

Industrials

GENE.L
5.3%
CHRG.L
48.7%

Energy

GENE.L

-

CHRG.L
6.1%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GENE.L vs. CHRG.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GENE.L
GENE.L Risk / Return Rank: 4848
Overall Rank
GENE.L Sharpe Ratio Rank: 4747
Sharpe Ratio Rank
GENE.L Sortino Ratio Rank: 4848
Sortino Ratio Rank
GENE.L Omega Ratio Rank: 4545
Omega Ratio Rank
GENE.L Calmar Ratio Rank: 5151
Calmar Ratio Rank
GENE.L Martin Ratio Rank: 5151
Martin Ratio Rank

CHRG.L
CHRG.L Risk / Return Rank: 6565
Overall Rank
CHRG.L Sharpe Ratio Rank: 6161
Sharpe Ratio Rank
CHRG.L Sortino Ratio Rank: 6161
Sortino Ratio Rank
CHRG.L Omega Ratio Rank: 8888
Omega Ratio Rank
CHRG.L Calmar Ratio Rank: 7373
Calmar Ratio Rank
CHRG.L Martin Ratio Rank: 4242
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GENE.L vs. CHRG.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for UBS ETF (IE) Global Gender Equality UCITS ETF (USD) A-acc (GENE.L) and WisdomTree Battery Solutions UCITS ETF - USD Acc (CHRG.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


GENE.LCHRG.LDifference
Sharpe ratioReturn per unit of total volatility

-0.41

Sortino ratioReturn per unit of downside risk

-0.50

Omega ratioGain probability vs. loss probability

1.28

1.54

-0.25

Calmar ratioReturn relative to maximum drawdown

2.49

3.54

-1.05

Martin ratioReturn relative to average drawdown

8.57

6.55

+2.02

GENE.L vs. CHRG.L - Sharpe Ratio Comparison

The current GENE.L Sharpe Ratio is 1.61, which is comparable to the CHRG.L Sharpe Ratio of 2.01. The chart below compares the historical Sharpe Ratios of GENE.L and CHRG.L, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


GENE.LCHRG.LDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.61

2.01

-0.41

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.66

0.19

+0.47

Sharpe Ratio (All Time)

Calculated using the full available price history

0.67

0.52

+0.14

Drawdowns

GENE.L vs. CHRG.L - Drawdown Comparison

The maximum GENE.L drawdown since its inception was -28.65%, smaller than the maximum CHRG.L drawdown of -52.64%. Use the drawdown chart below to compare losses from any high point for GENE.L and CHRG.L.


Loading charts...

Drawdown Indicators


GENE.LCHRG.LDifference

Max Drawdown

Largest peak-to-trough decline

-28.65%

-52.64%

+23.99%

Max Drawdown (1Y)

Largest decline over 1 year

-6.79%

-29.68%

+22.89%

Max Drawdown (3Y)

Largest decline over 3 years

-15.04%

-39.46%

+24.42%

Max Drawdown (5Y)

Largest decline over 5 years

-15.04%

-52.64%

+37.60%

Current Drawdown

Current decline from peak

-1.85%

-3.57%

+1.72%

Average Drawdown

Average peak-to-trough decline

-3.70%

-22.33%

+18.63%

Ulcer Index

Depth and duration of drawdowns from previous peaks

1.97%

16.07%

-14.10%

Volatility

GENE.L vs. CHRG.L - Volatility Comparison

The current volatility for UBS ETF (IE) Global Gender Equality UCITS ETF (USD) A-acc (GENE.L) is 2.59%, while WisdomTree Battery Solutions UCITS ETF - USD Acc (CHRG.L) has a volatility of 10.23%. This indicates that GENE.L experiences smaller price fluctuations and is considered to be less risky than CHRG.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


GENE.LCHRG.LDifference

Volatility (1M)

Calculated over the trailing 1-month period

2.59%

10.23%

-7.64%

Volatility (6M)

Calculated over the trailing 6-month period

8.14%

18.94%

-10.80%

Volatility (1Y)

Calculated over the trailing 1-year period

10.52%

52.29%

-41.77%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

12.96%

30.08%

-17.12%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

14.92%

29.54%

-14.62%

GENE.L vs. CHRG.L - Expense Ratio Comparison

GENE.L has a 0.20% expense ratio, which is lower than CHRG.L's 0.40% expense ratio.


Dividends

GENE.L vs. CHRG.L - Dividend Comparison

Neither GENE.L nor CHRG.L has paid dividends to shareholders.


Tickers have no history of dividend payments

Frequently Asked Questions


GENE.L and CHRG.L have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, GENE.L is cheaper at 0.20% per year. The better choice depends on whether you care most about return, fees, risk, or income.

GENE.L is cheaper with a 0.20% expense ratio, compared with 0.40% for CHRG.L.

GENE.L is categorized as Global Equities, while CHRG.L is Alternative Energy Equities. GENE.L tracks MSCI ACWI NR USD, while CHRG.L tracks WisdomTree Battery Solutions Index. They also come from different issuers: UBS and WisdomTree. Their fees differ too: 0.20% for GENE.L and 0.40% for CHRG.L.

Portfolio Optimizer

Find the right allocation for GENE.L and CHRG.L

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer